Feature | July 15, 2011| Dave Fornell

Intra-Cardiac Echo Aids EP Ablations, Structural Heart Procedures

Users say ICE offers more versatile imaging than TEE and will play a key role in transcatheter valve replacements

Catheter-based intra-cardiac echocardiography (ICE) is an imaging modality similar to intra-vascular ultrasound (IVUS). It allows imaging inside the heart to visualize cardiac structures and blood flow using Doppler imaging. The standard-of-care for this type of imaging is usually transesophageal echo (TEE), but ICE proponents say the intra-cardiac modality has several advantages.


The image quality is comparable to TEE, but the real advantage is the cardiologist controls the catheter instead of a sonographer, eliminating a second operator, explains Jay Lee, medical director of electophysiology (EP) at Hoag Heart and Vascular Institute, Newport Beach, Calif. He said ICE also provides more versatility than the limited view provided by TEE, because the catheter can be maneuvered to see more inside the heart and the aortic root. Unlike TEE, ICE does not require general anesthesia.


ICE has applications for structural heart imaging of the left atrial appendage (LAA), to aid in septal defect closures and visualizing the fossa ovalis, and plays a role in transcatheter valve replacement. It also is used in EP procedures for ablation catheter guidance.


EP Guidance
Lee primarily uses ICE for transcatheter EP ablations to treat atrial fibrillation (aFib), ventricular tachycardias and the pulmonary vein. In EP transcatheter ablation procedures, ICE confirms the exact location of the catheter tip to aid with more accurate ablations. ICE also can  help with safety monitoring of the pericardial space for tamponade or pericardial effusion caused in rare cases by either the transeptal puncture or the ablation, Lee said.


“It’s a wonderful tool to help us guide our procedures more accurately,” Lee said. “We also have found some new areas for ICE in the EP lab…I find it very useful with access and safety. We also find it useful for treating ventricular tachycardias.”
Hoag uses the Carto EP mapping system, which is compatible with Siemens’ ICE system. GE, Boston Scientific and St. Jude also offer ICE systems.


“It’s very practical when we are performing aFib catheterizations, because it offers real-time imaging of the heart,” Lee said.
He uses a transeptal puncture to feed the imaging catheter into the atrium he is ablating. Lee says a transeptal puncture is safer than other entry options, and used the ICE catheter to visualize exactly where the transeptal puncture is made.
The ICE system is used to create a map of the pulmonary artery and the atriums, and can help create a 3-D map of the ventricular anatomy, including details of the papillary muscles.  


ICE Catheters
Single element rotational (also referred to as radial) imaging catheters offer a similar view as IVUS and are good for close-up, near-field imaging, Lee said. Phased array ICE catheters allow side-fire, wedge-shaped images that are similar to conventional ultrasound imaging. Lee said phased array catheters offer better far-field imaging.


From his experience, Lee said rotational imaging offers about 2 cm field-of-view (FOV) of clear imaging (Boston Scientific says its system images up to 14 cm), which is good for the septum and the fossa ovalis. But due to the limited FOV, he said most EP labs will find phased array systems more useful, with vendors claiming imaging depths of up to 30 cm.


Boston Scientific’s Ultra ICE system uses radial ICE imaging, which is not steerable and is limited to 2-D imaging. The Siemens, GE and St. Jude systems are steerable and offer 2-D, color and spectral Doppler capabilities.


These catheters cost a couple thousand dollars each, which has led to resistance to widespread adoption, Lee said.


The Future of ICE
Lee said ICE works in tandem with EP mapping systems now, but further integration in the future will lead to more procedural accuracy. Mapping systems can import computed tomography (CT) images to use as a map of the heart, but the image is not in real time. Lee expects future systems to allow registration of the echo image with the mapping system for live imaging.


ICE is expected to become increasingly important to better guide an increasing number of transcatheter ablation procedures. Once transcatheter aortic and mitral valve heart valve replacement and LAA occlusion devices gain U.S. Food and Drug Administration (FDA) clearance, ICE is expected to see increased use for the accurate deployment of these devices.   
 

Related Content

anticoagulants, U.S. market, Technavio, 2020, trends
News | Antiplatelet and Anticoagulation Therapies| May 25, 2016
Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important trends expected...
Boston Scientific, FDA, IntelliNav XP ablation catheters, Rhythmia Mapping System

Rhythmia Mapping System image courtesy of Boston Scientific

Technology | Ablation Systems| May 23, 2016
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with...
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders| May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk
News | Atrial Fibrillation| May 19, 2016
Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision...
Johns Hopkins, virtual heart modeling tool, VARP, arrhythmias, implanted defibrillator

Examples of how the computer model would classify one patient at high risk for heart arrhythmia and another at low risk. Image courtesy of Royc Faddis/Johns Hopkins University.

News | Cardiac Diagnostics| May 17, 2016
May 17, 2016 — An interdisciplinary Johns Hopkins University team has developed a...
News | Ablation Systems| May 11, 2016
Patients with Wolff-Parkinson-White syndrome who receive catheter ablation to cure their abnormal heart rhythms are...
Medtronic, FDA approval, MR-conditional CRT-Ds, defibrillators, Amplia, Compia
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 11, 2016
Medtronic plc recently announced it received U.S. Food and Drug Administration (FDA) approval for the first and only...
Imricor, Vision-MR ablation catheter, clinical study, MRI guidance
News | Ablation Systems| May 10, 2016
Imricor Medical Systems announced enrollment of the first patients in a clinical study to evaluate the Vision-MR...
Medtronic, Micra transcatheter pacing system, study data, HRS 2016
News | Pacemakers| May 10, 2016
Medtronic plc announced clinical results highlighting the strong safety and performance profile of the miniaturized...
LivaNova, SonR hemodynamic sensor, CRT, heart failure, RESPOND CRT trial, HRS 2016
News | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2016
The first-ever trial using new SonR hemodynamic sensor technology proves to be safely and effectively applied in...
Overlay Init